Clinical Trial Update: Paclitaxel (Phyxol) and Cisplatin as First-line Chemotherapy for Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

This update describes a Phase 2 clinical trial evaluating paclitaxel (Phyxol) with cisplatin as first-line chemotherapy for metastatic breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Phyxol (paclitaxel)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN